Literature DB >> 30912958

Establishing MRI-guided prostate intervention at a UK Centre.

Alexander J King1, Tim Dudderidge1, Angela Darekar1, Katya Schimitz1, Rory Heard1, Chris Everitt1, Robert Chambers1, David Breen1.   

Abstract

OBJECTIVES: To describe our preliminary experience in establishing an MRI suite capable to deliver targeted prostate biopsy and cryoablation.
METHODS: This article includes a description of the necessary infrastructure alterations, scanning sequence suggestions, anaesthetic advice, and practical procedural considerations. We aim to examine the anticipated issues most UK centres would encounter and offer our experience in overcoming them. During this process we will also explore some of the technical aspects of MRI-guided prostate biopsy and cryoablation.
RESULTS: The clinical indication, treatment rationale, intervention strategy, and initial clinical outcomes are described for our first series of patients.
CONCLUSION: MRI-guided prostate intervention provides many theoretical advantages over traditional TRUS guidance. This article demonstrates some of the complexities encountered in establishing this technique in a UK centre, and the proposed solutions. ADVANCES IN KNOWLEDGE: This article gives an account of establishing the first MRI intervention suite in the UK. It demonstrates some of the logistical considerations, and offers the unit's early experience.

Entities:  

Mesh:

Year:  2019        PMID: 30912958      PMCID: PMC6592083          DOI: 10.1259/bjr.20180918

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

Review 1.  The anaesthetist's role in the setting up of an intraoperative MR imaging facility.

Authors:  T K Tan; J Goh
Journal:  Singapore Med J       Date:  2009-01       Impact factor: 1.858

Review 2.  MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results.

Authors:  Christiaan G Overduin; Jurgen J Fütterer; Jelle O Barentsz
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

3.  Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy.

Authors:  Wendy J M van de Ven; J P Michiel Sedelaar; Marloes M G van der Leest; Christina A Hulsbergen-van de Kaa; Jelle O Barentsz; Jurgen J Fütterer; Henkjan J Huisman
Journal:  Clin Imaging       Date:  2016-02-06       Impact factor: 1.605

4.  Trans-rectal Ultrasound-Guided Autologous Blood Injection in the Interprostatorectal Space Prior to Percutaneous MRI-Guided Cryoablation of the Prostate.

Authors:  Julien Garnon; Roberto Luigi Cazzato; Guillaume Koch; Ishaq Fahmi Uri; Georgia Tsoumakidou; Jean Caudrelier; Thibault Tricard; Afshin Gangi; Hervé Lang
Journal:  Cardiovasc Intervent Radiol       Date:  2017-12-11       Impact factor: 2.740

Review 5.  An Anesthesiologist's View of Tumor Ablation in the Radiology Suite.

Authors:  Annie Amin; Jason Lane; Thomas Cutter
Journal:  Anesthesiol Clin       Date:  2017-12

6.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

7.  Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.

Authors:  Christiaan G Overduin; Sjoerd F M Jenniskens; J P Michiel Sedelaar; Joyce G R Bomers; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

8.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.